Xing H. Lv

651 Dongfeng East Road
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications

Induction Paclitaxel-Cisplatin-Capecitabine for Nasopharyngeal Carcinoma.

Induction Paclitaxel-Cisplatin-Capecitabine for Nasopharyngeal Carcinoma.

Journal: NEJM evidence
Published: August 25, 2026

Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma.

Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma.

Journal: JAMA oncology
Published: March 19, 2026

Development of a simplified scoring system for MRI-detected retropharyngeal lymph node features to optimize AJCC 9th edition N classification in nasopharyngeal carcinoma.

Development of a simplified scoring system for MRI-detected retropharyngeal lymph node features to optimize AJCC 9th edition N classification in nasopharyngeal carcinoma.

Journal: Oral oncology
Published: November 01, 2025

KSRP-dependent immunogenic cell death induced by pyridazinone derivative IMB5036 drives antitumor immunity in neuroblastoma.

KSRP-dependent immunogenic cell death induced by pyridazinone derivative IMB5036 drives antitumor immunity in neuroblastoma.

Journal: FEBS letters
Published: October 27, 2025

Multimodal glyco-lipid-EBVDNA signature prognostic model for individualized risk stratification of locally advanced nasopharyngeal carcinoma.

Multimodal glyco-lipid-EBVDNA signature prognostic model for individualized risk stratification of locally advanced nasopharyngeal carcinoma.

Journal: European journal of nuclear medicine and molecular imaging
Published: October 20, 2025

Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial.

Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial.

Journal: Med (New York, N.Y.)
Published: October 02, 2025

Association between elemental concentrations and chemotherapy-related acute adverse events in patients with nasopharyngeal carcinoma.

Association between elemental concentrations and chemotherapy-related acute adverse events in patients with nasopharyngeal carcinoma.

Journal: Pharmacological reports : PR
Published: August 27, 2025

Realizing cascade regulation to photocarrier dynamics via heterophase homojunction construction and surface reconstruction for enhanced photoelectrochemical performance.

Realizing cascade regulation to photocarrier dynamics via heterophase homojunction construction and surface reconstruction for enhanced photoelectrochemical performance.

Journal: Journal of colloid and interface science
Published: August 06, 2025

Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial.

Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial.

Journal: Nature communications
Published: July 29, 2025

Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical Trial.

Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology
Published: June 18, 2025

The role of immunochemotherapy maintenance in metastatic nasopharyngeal carcinoma: insights from a cohort study in an endemic region.

The role of immunochemotherapy maintenance in metastatic nasopharyngeal carcinoma: insights from a cohort study in an endemic region.

Journal: Clinical & translational immunology
Published: March 04, 2025

Prognostic value of tumour-stroma ratio in nasopharyngeal carcinoma: a two-center retrospective study.

Prognostic value of tumour-stroma ratio in nasopharyngeal carcinoma: a two-center retrospective study.

Journal: Radiation oncology (London, England)
Published: February 17, 2025
Showing 1-12 of 98

Last Updated: 09/26/2026